comparemela.com

Latest Breaking News On - Lzheimer 39s disease - Page 8 : comparemela.com

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23. PRTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and […]

China
Chinese
Tran-nguyen
Hideki-garren
Movement-disorder-study-congress
Novo-nordisk
Promising-chinese-stocks-according
Prothena-corporation
Lzheimer-39s-disease
Clinical-programs
Gene-kinney
Mark-johnson

A millennial mom of 3 quit her job to help care for her boomer parents. She says she was unprepared to be in the 'sandwich generation.'

A millennial mom went from being a fintech professional to a member of the "sandwich generation," juggling boomer eldercare, childcare, and work.

Meagan-hency
Business-insider
Social-security
Lzheimer-39s-disease
Business-insider
Arkinson-39s-disease

Study links Agent Orange exposure to neurodegenerative diseases

D-CARE study highlights inclusive recruitment strategies for diverse dementia care

According to the Alzheimer's Association, more than 6.5 million Americans are living with Alzheimer's disease, and 1 in 3 older adults will die with the disease or another form of dementia.

United-states
Pennsylvania
California
University-of-texas
Texas
Danville
Spain
American
Americans
Los-angeles
Mia-yang
Atrium-health-wake-forest-baptist

Diabetes management program cuts dementia risk in type 2 patients

A recent study highlights the effectiveness of a multidisciplinary diabetes management program in reducing the risk of dementia in type 2 diabetes patients, emphasizing the importance of glycemic control for dementia prevention.

China
Hong-kong
Management-program
Care-management-program
Dementia-among-patients-with-diabetes
Primary-care-management
Image-credit
Africa-studio
Risk-assessment
Management-program-diabetes-mellitus
Dementia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.